Aimery de Gramont
Impact in
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 278
- Colorectal Cancer Treatments and Studies 244
- Cancer Treatment and Pharmacology 111
- Colorectal Cancer Surgical Treatments 52
-
- Gastric Cancer Management and Outcomes 75
- Lung Cancer Treatments and Mutations 34
- Co-authors
- Thierry André (155 shared papers)Christophe Louvet (117 shared papers)C. Boni (10 shared papers)Christophe Tournigand (87 shared papers)Josep Tabernero (39 shared papers)Tamas Hickish (14 shared papers)Marc Buyse (25 shared papers)Matilde Navarro (3 shared papers)
- Journals
- Journal of Clinical Oncology (112 papers)Annals of Oncology (33 papers)European Journal of Cancer (25 papers)Cancer (10 papers)Clinical Colorectal Cancer (6 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Aimery de Gramont
317 papers receiving 24.3k citations
Aimery de Gramont's Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 20.1k
- Hepatology 4.7k
- Pathology and Forensic Medicine 4.4k
- Pulmonary and Respiratory Medicine 6.8k
- Cancer Research 2.4k
Countries citing papers authored by Aimery de Gramont
This map shows the geographic impact of Aimery de Gramont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimery de Gramont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimery de Gramont more than expected).
Fields of papers citing papers by Aimery de Gramont
This network shows the impact of papers produced by Aimery de Gramont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimery de Gramont. The network helps show where Aimery de Gramont may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimery de Gramont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 333 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer Hit paper breakdown → | 2000 | 3040 |
| 2 | Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer Hit paper breakdown → | 2004 | 2694 |
| 3 | FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study Hit paper breakdown → | 2003 | 2290 |
| 4 | Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial Hit paper breakdown → | 2009 | 1603 |
| 5 | Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial Hit paper breakdown → | 2005 | 760 |
| 6 | Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Hit paper breakdown → | 1997 | 709 |
| 7 | OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study Hit paper breakdown → | 2006 | 583 |
| 8 | Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials Hit paper breakdown → | 2005 | 520 |
| 9 | 2009 | 484 | |
| 10 | Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database Hit paper breakdown → | 2016 | 434 |
| 11 | 2012 | 385 | |
| 12 | Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus Hit paper breakdown → | 2015 | 376 |
| 13 | 2007 | 372 | |
| 14 | 1996 | 367 | |
| 15 | 2012 | 354 | |
| 16 | 2006 | 345 | |
| 17 | 1997 | 311 | |
| 18 | 2014 | 283 | |
| 19 | 2009 | 262 | |
| 20 | 2007 | 260 |
About Aimery de Gramont
Aimery de Gramont is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery and Hepatology, having authored 333 papers that have together received 25.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (244 papers), Cancer Treatment and Pharmacology (111 papers), Genetic factors in colorectal cancer (76 papers), Gastric Cancer Management and Outcomes (75 papers), Colorectal Cancer Surgical Treatments (52 papers), Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Lung Cancer Treatments and Mutations (34 papers) and Colorectal and Anal Carcinomas (26 papers). The work is most often cited by research in Oncology (20.1k citations), Hepatology (4.7k citations), Pathology and Forensic Medicine (4.4k citations), Pulmonary and Respiratory Medicine (6.8k citations) and Cancer Research (2.4k citations). Aimery de Gramont has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Thierry André, Christophe Louvet, C. Boni, Christophe Tournigand, Josep Tabernero, Tamas Hickish, Marc Buyse, Matilde Navarro, C. Topham and John Bridgewater. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.